Prognostic value of the timing of immune checkpoint inhibitors infusion in patients with advanced hepatocellular carcinoma

被引：0
|
作者：
Pascale, Alina [1 ]
Allard, Marc Antoine [2 ]
Benamar, Amal [1 ]
Levy, Francis [2 ]
Adam, Rene [2 ]
Rosmorduc, Olivier [3 ]
机构：
[1] CHU Paul Brousse, AP HP, Villejuif, France
[2] Univ Paris Saclay, CHU Paul Brousse, AP HP, Villejuif, France
[3] Paris Sorbonne Univ, CHU Paul Brousse, AP HP, Villejuif, France
来源：
JOURNAL OF HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-491
引用
收藏
页码：S452 / S452
页数：1
相关论文
共 50 条
  • [31] Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma
    Abd El Aziz, Mohamed A.
    Facciorusso, Antonio
    Nayfeh, Tarek
    Saadi, Samer
    Elnaggar, Mohamed
    Cotsoglou, Christian
    Sacco, Rodolfo
    VACCINES, 2020, 8 (04) : 1 - 19
  • [32] Immune checkpoint inhibitors in the treatment of hepatocellular carcinoma
    Akbulut, Zeynep
    Aru, Basak
    Aydin, Furkan
    Demirel, Gulderen Yanikkaya
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [33] Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
    van Doorn, Diederick J.
    Takkenberg, Robert Bart
    Klumpen, Heinz-Josef
    PHARMACEUTICALS, 2021, 14 (01) : 1 - 23
  • [34] Neoadjuvant immune checkpoint inhibitors for hepatocellular carcinoma
    Akula, Vinita
    Chen, Lily
    Acikgoz, Yusuf
    Klein, Katherine
    Yavuz, Betul Gok
    Cevik, Lokman
    Demir, Tarik
    Manne, Ashish
    Sahin, Ilyas
    Kaseb, Ahmed
    Hasanov, Elshad
    NPJ PRECISION ONCOLOGY, 2025, 9 (01)
  • [35] Immune Checkpoint Inhibitors as Monotherapy or Within a Combinatorial Strategy in Advanced Hepatocellular Carcinoma
    Guardascione, Michela
    Toffoli, Giuseppe
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (17) : 1 - 19
  • [36] Immune-Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: A Synopsis of Response Rates
    Shek, Dmitrii
    Read, Scott A.
    Nagrial, Adnan
    Carlino, Matteo S.
    Gao, Bo
    George, Jacob
    Ahlenstiel, Golo
    ONCOLOGIST, 2021, 26 (07): : E1216 - E1225
  • [37] NLR stability predicts response to immune checkpoint inhibitors in advanced hepatocellular carcinoma
    Du, Jiajia
    Huang, Zhiyong
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [38] Liver injury by immune checkpoint inhibitors in patients with hepatocellular carcinoma.
    Personeni, Nicola
    Pressiani, Tiziana
    Capogreco, Antonio
    Dal Buono, Arianna
    D'Alessio, Antonio
    Prete, Maria Giuseppina
    Smiroldo, Valeria
    Bozzarelli, Silvia
    Giordano, Laura
    Aghemo, Alessio
    Santoro, Armando
    Rimassa, Lorenza
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
  • [39] Association between immune-related adverse events and efficacy of immune checkpoint inhibitors in patients with advanced hepatocellular carcinoma
    Wong, L.
    Ang, A.
    Ng, K.
    Tan, S. H.
    Choo, S. P.
    Tai, D.
    Lee, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [40] Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non- small cell lung cancer
    Rousseau, Adrien
    Tagliamento, Marco
    Auclin, Edouard
    Aldea, Mihaela
    Frelaut, Maxime
    Levy, Antonin
    Benitez, Jose C.
    Naltet, Charles
    Lavaud, Pernelle
    Botticella, Angela
    Grecea, Miruna
    Chaput, Nathalie
    Barlesi, Fabrice
    Planchard, David
    Besse, Benjamin
    EUROPEAN JOURNAL OF CANCER, 2023, 182 : 107 - 114
12345